Spineway (ALSPW) - Total Liabilities
Based on the latest financial reports, Spineway (ALSPW) has total liabilities worth €6.40 Million EUR (≈ $7.49 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Spineway - Total Liabilities Trend (2009–2025)
This chart illustrates how Spineway's total liabilities have evolved over time, based on quarterly financial data. See Spineway (ALSPW) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Spineway Competitors by Total Liabilities
The table below lists competitors of Spineway ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DSS Inc
NYSE MKT:DSS
|
USA | $66.02 Million |
|
INTL SCHOOL AUGS.AG NA ON
F:9JK
|
Germany | €5.59 Million |
|
My Rewards International Ltd
AU:MRI
|
Australia | AU$7.76 Million |
|
QX Resources Ltd
AU:QXR
|
Australia | AU$378.86K |
|
CAQ Holdings Ltd
AU:CAQ
|
Australia | AU$8.14 Million |
|
Reklaim Ltd
V:MYID
|
Canada | CA$821.02K |
|
Rayong Wire Industries Public Company Limited
BK:RWI
|
Thailand | ฿169.31 Million |
|
Lucapa Diamond Company Ltd
AU:LOM
|
Australia | AU$2.88 Million |
Liability Composition Analysis (2009–2025)
This chart breaks down Spineway's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALSPW stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Spineway's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Spineway (2009–2025)
The table below shows the annual total liabilities of Spineway from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €6.40 Million ≈ $7.49 Million |
+3.88% |
| 2024-12-31 | €6.17 Million ≈ $7.21 Million |
-15.05% |
| 2023-12-31 | €7.26 Million ≈ $8.48 Million |
+27.58% |
| 2022-12-31 | €5.69 Million ≈ $6.65 Million |
+21.31% |
| 2021-12-31 | €4.69 Million ≈ $5.48 Million |
-0.87% |
| 2020-12-31 | €4.73 Million ≈ $5.53 Million |
-24.69% |
| 2019-12-31 | €6.28 Million ≈ $7.34 Million |
-3.16% |
| 2018-12-31 | €6.49 Million ≈ $7.58 Million |
-20.31% |
| 2017-12-31 | €8.14 Million ≈ $9.52 Million |
-0.13% |
| 2016-12-31 | €8.15 Million ≈ $9.53 Million |
+37.19% |
| 2015-12-31 | €5.94 Million ≈ $6.95 Million |
-10.22% |
| 2014-12-31 | €6.62 Million ≈ $7.74 Million |
+58.25% |
| 2013-12-31 | €4.18 Million ≈ $4.89 Million |
+11.67% |
| 2012-12-31 | €3.74 Million ≈ $4.38 Million |
+29.12% |
| 2011-12-31 | €2.90 Million ≈ $3.39 Million |
+45.87% |
| 2010-12-31 | €1.99 Million ≈ $2.32 Million |
+23.56% |
| 2009-12-31 | €1.61 Million ≈ $1.88 Million |
-- |
About Spineway
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more